Internal Server Error

Ventana - About the company

Ventana is an acquired company based in Tucson (United States), founded in 1985 by Thomas Grogan. It operates as an Anatomic pathology solutions and companion diagnostics for improved patient care. Ventana has raised an undisclosed amount in funding. The company has 523 active competitors, including 146 funded and 113 that have exited. Its top competitors include companies like Guardant Health, Natera and Myriad Genetics.

Company Details

Anatomic pathology solutions and companion diagnostics for improved patient care. They empower pathology professionals and clinicians with advanced anatomic solutions. The company provides next-generation pathology lab instruments, cytology and tissue-based assays, and software solutions. These enable diagnostic certainty and empower clinicians to target personalized therapies. They offer digital pathology tools, workflow integration, and connectivity solutions. The company focuses on companion diagnostics, connecting patients to targeted therapies. They advance scientific innovation, breaking down barriers in anatomic pathology labs. Their solutions enhance clinical decision-making in areas like oncology, infectious diseases, and women's health. They provide services and support to healthcare professionals, researchers, and patients.
Social
X
Key Metrics
Founded Year
1985
Location
Tucson, United States
Stage
Acquired
Latest Funding Round
Ranked
Employee Count
563 as on Jul 31, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Acquired by Roche (Jun 25, 2007)

Ventana's acquisition details

Ventana got acquired by Roche on Jun 25, 2007.
Click here to take a look at Ventana's acquisition in detail
Sign up to download Ventana's company profile

Ventana's funding and investors

Ventana has raised funding over 1 round. Its latest funding round was a Series A round on Nov 26, 2012 for $*****. 1 investor participated in its latest round. Ventana has 4 institutional investors.

Here is the list of recent funding rounds of Ventana:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Nov 26, 2012
4921409
Series A
1538379
8342453
7440641
7506766
lockAccess funding benchmarks and valuations. Sign up today!

Ventana's founders and board of directors

Founder? Claim Profile
The founders of Ventana is Thomas Grogan.
Here are the details of Ventana's key team members:

Ventana's employee count trend

Ventana has 563 employees as of Jul 26. Here is Ventana's employee count trend over the years:
Employee count trend for Ventana
lockUncover Ventana's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Ventana's Competitors and alternates

Top competitors of Ventana include Guardant Health, Natera and Myriad Genetics. Here is the list of Top 10 competitors of Ventana, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Guardant Health
Guardant Health
2012, Redwood City (United States), Public
Developer of digital sequencing technology for cancer detection
$557M
79/100
2nd
Logo for Natera
Natera
2004, Redwood City (United States), Public
Developer of cell-free DNA testing for oncology, women’s health, and organ health
$152M
77/100
3rd
Developer of molecular diagnostics and personalized medicine for cancer
-
72/100
4th
Logo for Foundation Medicine
Foundation Medicine
2010, Cambridge (United States), Acquired
Provider of genomics-based diagnostics test for cancer
$96.5M
71/100
5th
Logo for Exact Sciences
Exact Sciences
1995, Madison (United States), Acquired
Provider of non-invasive molecular diagnostic testing solutions for cancer
-
71/100
6th
Logo for Caris Life Sciences
Caris Life Sciences
1996, Irving (United States), Public
Developer of panomic disease profiling technologies for cancer precision medicine
$1.23B
70/100
7th
Logo for Prenetics
Prenetics
2009, Hong Kong (China), Public
Online platform for genetic and diagnostic health testing that helps identify health risks
$67.6M
70/100
8th
Logo for BillionToOne
BillionToOne
2015, San Francisco (United States), Public
Provider of cell-free cancer liquid biopsy test
$389M
69/100
9th
Logo for Delfi Diagnostics
Delfi Diagnostics
2019, Baltimore (United States), Series B
Provider of DNA sequencing for cancer detection
$332M
68/100
10th
Logo for Foresight Diagnostics
Foresight Diagnostics
2020, Aurora (United States), Acquired
Developer of minimally-invasive liquid biopsy test for the detection of cancer
$104M
66/100
134th
Logo for Ventana
Ventana
1985, Tucson (United States), Acquired
Anatomic pathology solutions and companion diagnostics for improved patient care
-
38/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Ventana's competitors? Click here to see the top ones

Ventana's Investments and acquisitions

Ventana has a total of 1 investment in Idun Pharmaceuticals. Ventana has not made any acquisitions as of now.

Reports related to Ventana

Here is the latest report on Ventana's geography:

News related to Ventana

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Ventana

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford